tiprankstipranks
Trending News
More News >
Paradigm Biopharmaceuticals Ltd. (AU:PAR)
ASX:PAR
Australian Market

Paradigm Biopharmaceuticals Ltd. (PAR) Ratios

Compare
22 Followers

Paradigm Biopharmaceuticals Ltd. Ratios

AU:PAR's free cash flow for Q2 2025 was AU$-0.12. For the 2025 fiscal year, AU:PAR's free cash flow was decreased by AU$ and operating cash flow was AU$-380.10. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
7.22 4.89 6.02 13.98 32.21
Quick Ratio
7.22 4.89 6.02 13.98 32.21
Cash Ratio
5.30 4.32 5.07 12.26 30.89
Solvency Ratio
-16.32 -3.86 -4.66 -5.23 -2.89
Operating Cash Flow Ratio
-19.63 -3.46 -4.11 -6.03 -3.00
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 10.09M
Net Current Asset Value
AU$ 20.67MAU$ 50.39MAU$ 38.79MAU$ 74.46MAU$ 104.19M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.01 <0.01 0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 <0.01 0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.15 1.25 1.20 1.08 1.04
Debt Service Coverage Ratio
-4.07K -3.17K -1.36K -895.63 -352.73
Interest Coverage Ratio
-4.54K -3.61K -1.64K -1.12K -496.38
Debt to Market Cap
0.00 0.00 0.00 0.00 >-0.01
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.27 0.95 0.83 1.67 6.56
Profitability Margins
Gross Profit Margin
86.34%-268.87%-325.38%-1404.61%0.00%
EBIT Margin
-98306.89%-126038.89%-59304.70%-207339.00%0.00%
EBITDA Margin
-98083.89%-126309.13%-59095.03%-205029.78%0.00%
Operating Profit Margin
-99077.69%-126637.75%-59338.96%-206051.97%0.00%
Pretax Profit Margin
-98328.73%-126074.01%-59340.83%-207522.57%0.00%
Net Profit Margin
-89138.58%-111013.71%-49542.54%-166896.27%0.00%
Continuous Operations Profit Margin
-89138.58%-111013.71%-49542.54%-166896.27%0.00%
Net Income Per EBT
90.65%88.05%83.49%80.42%77.12%
EBT Per EBIT
99.24%99.55%100.00%100.71%94.02%
Return on Assets (ROA)
-214.14%-77.40%-77.43%-40.45%-10.95%
Return on Equity (ROE)
-246.38%-96.71%-92.76%-43.82%-11.37%
Return on Capital Employed (ROCE)
-271.29%-109.60%-109.69%-53.60%-15.56%
Return on Invested Capital (ROIC)
-244.70%-96.32%-91.26%-43.03%-11.99%
Return on Tangible Assets
-239.96%-80.96%-82.21%-41.91%-11.24%
Earnings Yield
-68.96%-18.61%-17.48%-7.96%-1.94%
Efficiency Ratios
Receivables Turnover
0.01 <0.01 0.01 <0.01 0.00
Payables Turnover
<0.01 0.01 0.05 0.06 0.08
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.35 0.14 0.14 0.03 0.00
Asset Turnover
<0.01 <0.01 <0.01 <0.01 0.00
Working Capital Turnover Ratio
<0.01 <0.01 <0.01 <0.01 0.00
Cash Conversion Cycle
-86.37K 27.40K 23.28K 145.22K -4.71K
Days of Sales Outstanding
28.19K 53.14K 30.95K 151.11K 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
114.57K 25.73K 7.68K 5.89K 4.71K
Operating Cycle
28.19K 53.14K 30.95K 151.11K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-0.22 -0.16 -0.13 -0.16 -0.05
Free Cash Flow Per Share
-0.22 -0.16 -0.13 -0.16 -0.05
CapEx Per Share
0.22 0.00 0.00 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
-1.00 0.00 0.00 -1.10K -77.09
Capital Expenditure Coverage Ratio
-1.00 0.00 0.00 -1.10K -77.09
Operating Cash Flow Coverage Ratio
-275.54 -132.25 -52.22 -46.46 -11.55
Operating Cash Flow to Sales Ratio
-1.00K -966.34 -406.51 -1.70K 0.00
Free Cash Flow Yield
-77.53%-16.20%-14.34%-8.12%-1.61%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.45 -5.37 -5.72 -12.56 -51.48
Price-to-Sales (P/S) Ratio
1.29K 5.97K 2.83K 20.96K 0.00
Price-to-Book (P/B) Ratio
3.57 5.20 5.31 5.50 5.85
Price-to-Free Cash Flow (P/FCF) Ratio
-1.29 -6.17 -6.97 -12.32 -61.94
Price-to-Operating Cash Flow Ratio
-1.29 -6.17 -6.97 -12.33 -62.75
Price-to-Earnings Growth (PEG) Ratio
-0.13 -0.43 0.00 -0.07 1.11
Price-to-Fair Value
3.57 5.20 5.31 5.50 5.85
Enterprise Value Multiple
-1.05 -3.77 -3.96 -8.56 -33.76
EV to EBITDA
-1.05 -3.77 -3.96 -8.56 -33.76
EV to Sales
1.03K 4.77K 2.34K 17.54K 0.00
EV to Free Cash Flow
-1.02 -4.93 -5.76 -10.31 -51.86
EV to Operating Cash Flow
-1.02 -4.93 -5.76 -10.32 -52.53
Tangible Book Value Per Share
0.07 0.18 0.16 0.35 0.51
Shareholders’ Equity Per Share
0.08 0.19 0.18 0.37 0.52
Tax and Other Ratios
Effective Tax Rate
0.09 0.12 0.17 0.20 0.23
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 0.00
Net Income Per Share
-0.20 -0.18 -0.16 -0.16 -0.06
Tax Burden
0.91 0.88 0.83 0.80 0.77
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
886.53 1.13K 492.43 1.63K 0.00
SG&A to Revenue
94.47 140.39 100.15 425.70 0.00
Stock-Based Compensation to Revenue
0.00 20.03 41.28 156.02 0.00
Income Quality
1.12 0.87 0.82 1.02 0.82
Currency in AUD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis